Completed PHASE3 INTERVENTIONAL 2-arm NCT00598156

Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva (ACT)

Avastin and Chemotherapy Followed by Avastin Alone or in Combination With Tarceva for the Treatment of Metastatic Colorectal Cancer.

Sponsor: Hoffmann-La Roche

Conditions Metastatic Colorectal Cancer

Interventions bevacizumab (Avastin) erlotinib (Tarceva)

Updated 6 times since 2017 Last updated: Apr 19, 2013 Started: Jun 30, 2007 Primary completion: Oct 31, 2009 Completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Metastatic Colorectal Cancer, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoffmann-La Roche
Lund University Hospital

Data source: Lund University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Copenhagen, Denmark , Esbjerg, Denmark , Herning, Denmark , Hillerød, Denmark , Jönköping, Sweden , Kalmar, Sweden , Lund, Sweden , Malmo, Sweden , Odense, Denmark , Roskilde, Denmark and 5 more locations